vs

Side-by-side financial comparison of Sunlands Technology Group (STG) and SurgePays, Inc. (SURG). Click either name above to swap in a different company.

SurgePays, Inc. is the larger business by last-quarter revenue ($16.2M vs $10.1M, roughly 1.6× Sunlands Technology Group). Sunlands Technology Group runs the higher net margin — 24.0% vs -85.6%, a 109.6% gap on every dollar of revenue. Over the past eight quarters, Sunlands Technology Group's revenue compounded faster (0.6% CAGR vs -28.2%).

STG Partners, LLC (STG) is an American private equity firm and based in Menlo Park, California. Its predecessor, Symphony Technology Group ("Symphony") was founded in 2002 by Romesh Wadhwani, William Chisholm, and Bryan Taylor. In 2017, Symphony was reorganized as STG Partners. As of March 2025, STG Partners managed approximately $12 billion in 19 pooled investment vehicle for its clients. The firm itself has less than one billion dollars in assets.

SurgePays, Inc. is a U.S.-headquartered fintech and telecommunications company focused on serving underbanked and low-income communities across the country. It offers prepaid wireless plans, reloadable debit cards, digital banking solutions, and daily consumer products through a nationwide network of independent local retail partners such as convenience stores.

STG vs SURG — Head-to-Head

Bigger by revenue
SURG
SURG
1.6× larger
SURG
$16.2M
$10.1M
STG
Higher net margin
STG
STG
109.6% more per $
STG
24.0%
-85.6%
SURG
Faster 2-yr revenue CAGR
STG
STG
Annualised
STG
0.6%
-28.2%
SURG

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
STG
STG
SURG
SURG
Revenue
$10.1M
$16.2M
Net Profit
$2.4M
$-13.9M
Gross Margin
88.5%
-14.8%
Operating Margin
26.5%
-79.1%
Net Margin
24.0%
-85.6%
Revenue YoY
68.7%
Net Profit YoY
30.0%
EPS (diluted)
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STG
STG
SURG
SURG
Q4 25
$16.2M
Q3 25
$10.1M
$18.7M
Q2 25
$9.3M
$11.5M
Q1 25
$10.6M
Q4 24
$9.7M
$9.6M
Q3 24
$4.8M
Q2 24
$10.0M
$15.1M
Q1 24
$31.4M
Net Profit
STG
STG
SURG
SURG
Q4 25
$-13.9M
Q3 25
$2.4M
$-7.5M
Q2 25
$1.4M
$-7.1M
Q1 25
$-7.6M
Q4 24
$1.8M
$-19.8M
Q3 24
$-14.3M
Q2 24
$2.2M
$-12.9M
Q1 24
$1.2M
Gross Margin
STG
STG
SURG
SURG
Q4 25
-14.8%
Q3 25
88.5%
-13.9%
Q2 25
85.2%
-23.0%
Q1 25
-27.8%
Q4 24
83.3%
-117.0%
Q3 24
-164.2%
Q2 24
85.2%
-22.8%
Q1 24
26.0%
Operating Margin
STG
STG
SURG
SURG
Q4 25
-79.1%
Q3 25
26.5%
-37.2%
Q2 25
15.2%
-59.1%
Q1 25
-71.7%
Q4 24
13.4%
-209.0%
Q3 24
-299.4%
Q2 24
-72.1%
Q1 24
5.6%
Net Margin
STG
STG
SURG
SURG
Q4 25
-85.6%
Q3 25
24.0%
-40.1%
Q2 25
15.4%
-61.5%
Q1 25
-72.2%
Q4 24
18.2%
-206.5%
Q3 24
-299.3%
Q2 24
21.5%
-85.3%
Q1 24
3.9%
EPS (diluted)
STG
STG
SURG
SURG
Q4 25
$-0.68
Q3 25
$-0.38
Q2 25
$-0.36
Q1 25
$-0.38
Q4 24
$-1.07
Q3 24
$-0.73
Q2 24
$0.31
$-0.66
Q1 24
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STG
STG
SURG
SURG
Cash + ST InvestmentsLiquidity on hand
$15.1M
$1.7M
Total DebtLower is stronger
$13.3M
Stockholders' EquityBook value
$17.7M
$-15.3M
Total Assets
$41.2M
$8.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STG
STG
SURG
SURG
Q4 25
$1.7M
Q3 25
$15.1M
$2.5M
Q2 25
$4.4M
Q1 25
$5.4M
Q4 24
$15.6M
$11.8M
Q3 24
$23.7M
Q2 24
$18.7M
Q1 24
Total Debt
STG
STG
SURG
SURG
Q4 25
$13.3M
Q3 25
$12.0M
Q2 25
$9.6M
Q1 25
$3.6M
Q4 24
$1.5M
$4.0M
Q3 24
$4.4M
Q2 24
$1.8M
$4.8M
Q1 24
$5.2M
Stockholders' Equity
STG
STG
SURG
SURG
Q4 25
$-15.3M
Q3 25
$17.7M
$-6.4M
Q2 25
$12.6M
$116.1K
Q1 25
$7.8M
Q4 24
$10.7M
$15.3M
Q3 24
$33.2M
Q2 24
$7.6M
$46.2M
Q1 24
$56.0M
Total Assets
STG
STG
SURG
SURG
Q4 25
$8.5M
Q3 25
$41.2M
$14.5M
Q2 25
$40.3M
$15.2M
Q1 25
$15.7M
Q4 24
$42.4M
$24.0M
Q3 24
$41.5M
Q2 24
$41.3M
$56.4M
Q1 24
$69.6M
Debt / Equity
STG
STG
SURG
SURG
Q4 25
Q3 25
Q2 25
82.67×
Q1 25
0.46×
Q4 24
0.14×
0.26×
Q3 24
0.13×
Q2 24
0.24×
0.10×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STG
STG
SURG
SURG
Operating Cash FlowLast quarter
$-3.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STG
STG
SURG
SURG
Q4 25
$-3.6M
Q3 25
$-4.6M
Q2 25
$-6.1M
Q1 25
$-7.0M
Q4 24
$-7.9M
Q3 24
$-13.3M
Q2 24
$-4.1M
Q1 24
$4.0M
Cash Conversion
STG
STG
SURG
SURG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
3.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons